GeneTex

  • Country / Location Selection

United States (US)

ATG7 blocking peptide

Cat. No. GTX16985-PEP

Application

 Neutralizing/Inhibition
Package
50 μg ($139)
See all ATG7 products
PRODUCT

Summary

ATG7 peptide is used for blocking the activity of ATG7 antibody (catalog number GTX16985).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Autophagy Related 7 , Apg7-Like , Apg7L , Gsa7 , Atg7

Background

This gene was identified based on homology to Pichia pastoris GSA7 and Saccharomyces cerevisiae APG7. In the yeast, the protein appears to be required for fusion of peroxisomal and vacuolar membranes. The protein shows homology to the ATP-binding and catalytic sites of the E1 ubiquitin activating enzymes. [provided by RefSeq, Jan 2009]

Research Area

REFERENCE

There are currently no references for ATG7 blocking peptide (GTX16985-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for ATG7 blocking peptide (GTX16985-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139